Document is current
Any future updates will be listed below
-
Authors
Rodriguez-Piñeiro, Ana M.
Jaudas, Florian
Klymiuk, Nikolai
Bähr, Andrea
Hansson, Gunnar C.
Ermund, Anna https://orcid.org/0000-0002-3233-043X
-
Funding
Funding for this research was provided by:
European Research Council (694181)
Vetenskapsrådet (2017-00958)
Swedish Cancer Foundation
Knut och Alice Wallenbergs Stiftelse (2017.0028)
IngaBritt och Arne Lundbergs Forskningsstiftelse
Sahlgrenska University Hospital
National Institute of Allergy and Infectious Diseases (U01AI095473)
The Swedish Foundation for Strategic Research
Erica Lederhausen’s Foundation
Lederhausen’s Center for CF Research at the University of Gothenburg
Cystic Fibrosis Foundation Therapeutics (CFFT, Hansson14X0)
Wilhelm and Martina Lundgren’s Foundation
The Swedish Heart and Lung Foundation (20160241)
the Swedish Cystic Fibrosis Foundation
Magnus Bergvall´s Foundation
University of Gothenburg
- License Information
-
More Information
Article History
Received: 15 November 2022
Accepted: 4 March 2023
First Online: 16 March 2023
Declarations
:
: Experimental procedures were performed in accordance with the EU Directive 2010/63/EU for the care and use of laboratory animals, the NIH and ARRIVE guidelines. Ethical permits for protocols were obtained from Regierungen von Oberbayern, Munich, Germany (AZ55.2-1-54-2531-78-07) and Jordbruksverket, Jönköping, Sweden (Dnr 6.7.18-12708/2019).
: Not applicable.
: The authors declare that they have no competing interests.
